KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

Knoll Capital Management, LLC's Holding History (CIK: 0001325083)

Note: Option positions (PUT/CALL) are excluded.

Q3 2017
Shares 200,000 Value ($000) $1,420 Avg Close Range
Q2 2017
Shares 200,000 Value ($000) $1,446 Avg Close Range
Q1 2017
Shares 200,000 Value ($000) $1,232 Avg Close Range
Q4 2016
Shares 200,000 Value ($000) $1,172 Avg Close Range
Q3 2016
Shares 200,000 Value ($000) $1,030 Avg Close Range
Q2 2016
Shares 200,000 Value ($000) $1,324 Avg Close Range
Q1 2016
Shares 200,000 Value ($000) $934 Avg Close Range
Q4 2015
Shares 200,000 Value ($000) $1,010 Avg Close Range
Q3 2015
Shares 200,000 Value ($000) $704 Avg Close Range
Q2 2015
Shares 200,000 Value ($000) $1,996 Avg Close Range
Q1 2015
Shares 200,000 Value ($000) $2,546 Avg Close Range
Q4 2014
Shares 200,000 Value ($000) $2,830 Avg Close Range
Q3 2014
Shares 200,000 Value ($000) $2,750 Avg Close Range
Q2 2014
Shares 200,000 Value ($000) $3,076 Avg Close Range
Q1 2014
Shares 200,000 Value ($000) $3,408 Avg Close Range
Q4 2013
Shares 200,000 Value ($000) $2,592 Avg Close Range
Q3 2013
Shares 100,000 Value ($000) $1,009 Avg Close Range
Q2 2013
Shares 100,000 Value ($000) $747 Avg Close Range